AIM ImmunoTech (AIM) Shares Outstanding (Diluted) (2022 - 2026)
AIM ImmunoTech (AIM) reported Shares Outstanding (Diluted) of 17.12 million for Q2 2026, compared with 759,289 a year earlier and up 293.4% from the prior quarter.
Powered by 
Analysis
AIM ImmunoTech (AIM) Shares Outstanding (Diluted) (2022 - 2026) Analysis & Trends
For FY2025, AIM ImmunoTech posted Shares Outstanding (Diluted) of 1.62 million, up 189.0% from FY2024.
- Shares Outstanding (Diluted) has increased for three consecutive years, with a three-year compound annual growth rate of 49.9% (FY2022 to FY2025).
- By year, Shares Outstanding (Diluted) came in at 560,169 in FY2024 (+15.3%), 485,854 in FY2023 (+1.1%) and 480,473 in FY2022.
- The Q2 2026 figure ranks as the highest quarterly Shares Outstanding (Diluted) in data going back to Q2 2022.
- Across the past five years, year-over-year growth in Shares Outstanding (Diluted) ran from 0.8% in Q2 2023 to 518.7% in Q1 2026.
- Per Business Quant data, the three quarters before Q2 2026 came in at 4.35 million (Q1 2026), 1.62 million (Q4 2025) and 2.09 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | AIM ImmunoTech | 3.08 Mn | -18.22 Mn | 21,000.00 | 17.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.12 Mn |
| Mar 31, 2026 | 4.35 Mn |
| Dec 31, 2025 | 1.62 Mn |
| Sep 30, 2025 | 2.09 Mn |
| Jun 30, 2025 | 759,289.00 |
| Mar 31, 2025 | 703,299.00 |
| Dec 31, 2024 | 560,169.00 |
| Sep 30, 2024 | 576,770.00 |
| Jun 30, 2024 | 528,375.00 |
| Mar 31, 2024 | 494,580.00 |
| Dec 31, 2023 | 485,854.00 |
| Sep 30, 2023 | 486,352.00 |
| Jun 30, 2023 | 484,113.00 |
| Mar 31, 2023 | 484,000.00 |
| Dec 31, 2022 | 480,473.00 |
| Sep 30, 2022 | 480,792.00 |
| Jun 30, 2022 | 480,341.00 |
API Access
AIM ImmunoTech Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=AIM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "AIM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=AIM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();